Pseudallescheria boydii infections treated with ketoconazole. Clinical evaluations of seven paients and in vitro susceptibility results

J. N. Galgiani, D. A. Stevens, J. R. Graybill, D. L. Stevens, A. J. Tillinghast, H. B. Levine

Research output: Contribution to journalArticle

63 Scopus citations

Abstract

Seven patients infected with Pseudallecheria boydii were treated with oral ketoconazole, 200 to 600 mg/day for one to 13 months. Five patients had pulmonary infections; two had skeletal infections. Improvement of pretreatment abnormalities occurred in five patients, one of whom had concurrent arthrodesis of his infected knee. The other two patients were subsequently healed by surgical resection of their pulmonary lesions. Ketoconazole appeared less active than miconazole against 22 clinical isolates of P boydii when tested by two in vitro methods. We conclude that ketoconazole is effective treatment for some patients infected with P boydii, although this may not be predicted by current in vitro susceptibility tests. Further experience is needed to establish the optimal use of ketoconazole with respect to its dosage, duration of administration and concurrent surgical resection.

Original languageEnglish (US)
Pages (from-to)219-224
Number of pages6
JournalCHEST
Volume86
Issue number2
DOIs
StatePublished - Jan 1 1984

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Pseudallescheria boydii infections treated with ketoconazole. Clinical evaluations of seven paients and in vitro susceptibility results'. Together they form a unique fingerprint.

  • Cite this